STOCKHOLM, Oct. 1, 2018 /PRNewswire/ -- The shareholders of IRRAS AB ("IRRAS"), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for various brain pathologies, voted to approve Eva Nilsagård as new member of the Group's board of...
from PR Newswire: //https://ift.tt/2QiTcfx
No comments:
Post a Comment